摘要
目的了解多重耐药鲍曼不动杆菌(MDR-AB)医院感染的直接经济损失。方法选取重庆市某三级甲等综合医院2014年9月—2016年8月住院患者中发生MDR-AB医院感染的65例住院患者(设为病例组),采用1∶1配对病例对照研究方法,按配对条件选取同期未发生医院感染的住院患者65例(设为对照组),分析比较MDR-AB医院感染的直接经济损失。结果病例组住院总费用、药占比、住院日数中位数分别为167 579.56元、37.40%、52 d;对照组则为59 386.77元、31.85%、27 d,MDR-AB医院感染所导致的平均直接经济损失为108 192.79元,主要为药费、护理费、治疗费、检验费,其中药费所占比例最高;MDR-AB医院感染延长的平均住院日数为25 d;病例组各分类费用高于对照组,差异均有统计学意义(均P<0.05)。结论 MDR-AB医院感染所导致的经济损失严重,增加药占比,延长住院时间,应重视其预防与控制。
Objective To understand direct economic loss due to healthcareassociated infection(HAI) with multidrugresistant Acinetobacter baumannii(MDRAB). Methods65 hospitalized patients with MDRAB in a tertiary firstclass general hospital in Chongqing City between September 2014 and August 2016 were as case group, a 1∶1 matched casecontrol study was adopted, 65 hospitalized patients without HAI during the same period were selected as control group, direct economic loss due to MDRAB HAI was analyzed and compared. ResultsThe median of hospitalization expense, medicine proportion, and length of hospital stay in case group were 167 579.56 yuan, 37.40%, and 52 days respectively, while those in control group were 59 386.77 yuan, 31.85%, and 27 days respectively, the average direct economic loss due to MDRAB HAI was 108 192.79 yuan, mainly for fees of medicine, nursing, treatment, and laboratory detection, the proportion of medicine was the highest; the average extension of length of hospital stay due to MDRAB HAI was 25 days; each expense in case group was higher than that of control group, difference were all statistically significant (all P〈0.05). ConclusionEconomic loss due to MDRAB HAI is serious, proportion of medicine is increased, and length of hospital stay is prolonged, prevention and control should be paid attention.
作者
吴晓英
丁丽娜
吴修建
WU Xiaoying;DING Lina;WU Xiujian(Yongchuan Hospital,Chongqing Medical University,Chongqing 402160,China)
出处
《中国感染控制杂志》
CAS
北大核心
2018年第8期735-738,共4页
Chinese Journal of Infection Control
关键词
多重耐药
鲍曼不动杆菌
多重耐药鲍曼不动杆菌
医院感染
经济损失
multidrug resistance
Acinetobacter baumannii multidrug resistant
Acinetobacter baumannii healthcare associated
infection economic loss